Home > Healthcare > Medical Devices > Diagnostic Devices > Hepatitis Diagnostic Tests Market

Hepatitis Diagnostic Tests Market Trends

Report ID: GMI5626
Published Date: May 2023
Report Format: PDF

Download Free Sample

Hepatitis Diagnostic Tests Market Trends

Rising number of patients suffering is one of the major health concerns in several countries worldwide. Hepatitis is a viral infection that can cause liver inflammation and, if left untreated, can lead to cirrhosis, liver failure, and liver cancer. Hepatitis is a major cause of liver disease and can have serious long-term health consequences. Some of the major factors influencing the upsurge in patient volume include lack of awareness regarding the disease and treatment options coupled with limited access to testing and diagnosis. However, increasing initiatives by government authorities for hepatitis awareness and disease screening associated with providing cost effective diagnostic tests by market players is projected to augment the product adoption.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for hepatitis diagnostic tests was around USD 3.4 billion in 2022 and will record a 5.8% CAGR between 2023 to 2032.

Reagents & kits was USD 2.3 billion in 2022 owing to benefits offered by kits and reagents in precise & accurate screening of hepatitis disease.

Abbott Laboratories, Autobio Diagnostics, Analytik Jena, DiaSorin, Grifols SA, Danher Corporation, Roche Molecular Diagnostics, Hologic Inc., MedMira Inc, and Ortho-Clinical Diagnostics are the top companies in the global market.

North America hepatitis diagnostic tests market size was about USD 1.4 billion in 2022 and is anticipated to expand due to growing prevalence of hepatitis and related chronic diseases across the region.